Skip to main content
Supplement ScienceSupplementScience
meta analysis

Spirulina and Cholesterol: Two Meta-Analyses

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

The 2016 review included seven randomized trials and reported reductions in LDL cholesterol, total cholesterol and...

The 2016 review included seven randomized trials and reported reductions in LDL cholesterol, total cholesterol and triglycerides. The 2018 review included 12 trials and also found improved lipid markers. Their numerical estimates differ and must not be combined into a single effect claim. Neither review establishes a reduction in heart attacks or an alternative to indicated medication.

Key Findings

  • Serban 2016 included seven randomized trials. Total cholesterol decreased by 46.76 mg/dL (95% CI −67.31 to −26.22), and LDL cholesterol by 41.32 mg/dL (−60.62 to −22.03). [1]
  • In that same review, triglycerides decreased by 44.23 mg/dL (95% CI −50.22 to −38.24) and HDL increased by 6.06 mg/dL (2.37 to 9.76). [1]
  • The 2016 meta-regression did not establish a dose-dependent effect; higher doses were not shown to consistently work better. [1]
  • Huang 2018 included 12 trials with 14 arms. Its pooled estimates were −36.60 mg/dL for total cholesterol, −33.16 mg/dL for LDL and −39.20 mg/dL for triglycerides. [2]
  • The 2014 Cretan study followed 52 people taking 1 g/day for 12 weeks. It was a prospective study without a randomized placebo comparison, so its before-and-after changes provide weaker causal evidence. [3]

Study Details

A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations
Serban MC, Sahebkar A, Dragan S, Stoichescu-Hogea G, Ursoniu S, Andrica F, Banach M — Clinical nutrition (Edinburgh, Scotland) (2016)
Seven randomized trials; LDL WMD −41.32 mg/dL, with no established dose-response in meta-regression.
Participant count not reportedModerate
Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure
Huang H, Liao D, Pu R, Cui Y — Diabetes, metabolic syndrome and obesity : targets and therapy (2018)
Twelve trials with 14 arms, doses 1–19 g/day and durations 2–48 weeks; LDL WMD −33.16 mg/dL.
Participant count not reportedModerate
The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study
Mazokopakis EE, Starakis IK, Papadomanolaki MG, Mavroeidi NG, Ganotakis ES — Journal of the science of food and agriculture (2014)
Prospective 12-week study of 1 g/day in dyslipidemia; lipid changes were measured from baseline without a randomized placebo comparison.
52 participantsModerate

Practical Takeaway

These reviews suggest improvements in lipid markers, but differences in populations, doses and trial methods make one guaranteed effect or optimal dose inappropriate. Lipid changes do not establish cardiovascular outcome benefits. Spirulina should not replace prescribed lipid-lowering treatment based on these reviews.

Summary

The 2016 seven-trial and 2018 twelve-trial meta-analyses of spirulina, with each review's lipid estimates reported separately.

Related Supplements

Related Conditions

Product Reviews

Learn More

Frequently Asked Questions

Why do different summaries report different LDL reductions?

The 2016 and 2018 reviews included different trial sets and reported different pooled estimates. The 2016 LDL estimate was −41.32 mg/dL; the 2018 estimate was −33.16 mg/dL. Combining one review's trial count with the other's outcomes misrepresents the evidence.

Does a higher dose work better?

The 2016 meta-regression described effects as independent of dose. The later review covered a wide dose range and does not establish one best dose for everyone.

Does lowering a lipid marker prove fewer heart attacks?

No. The cited reviews assessed biomarkers. A cardiovascular-event benefit requires direct clinical-outcome evidence.

Do these studies prove spirulina is safe with statins?

No. The cited reviews do not establish the safety of every statin–supplement combination. A clinician or pharmacist should assess the actual product and medication regimen.

Continue Reading

References

  1. Serban MC, Sahebkar A, Dragan S, Stoichescu-Hogea G, Ursoniu S, Andrica F, Banach M (2016). A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clinical nutrition (Edinburgh, Scotland). DOI PubMed
  2. Huang H, Liao D, Pu R, Cui Y (2018). Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure. Diabetes, metabolic syndrome and obesity : targets and therapy. DOI PubMed
  3. Mazokopakis EE, Starakis IK, Papadomanolaki MG, Mavroeidi NG, Ganotakis ES (2014). The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study. Journal of the science of food and agriculture. DOI PubMed